Press Release: Partnership with Itamar MedicalReflecting an ongoing commitment to optimizing workflow and enabling better coordination of care for sleep apnea patients, Itamar Medical® and Somnoware Healthcare Systems announced a strategic alliance based on a shared vision for the sleep industry. According to leadership from both companies, aligning at the technology, marketing and business levels will drive new growth opportunities and increase their collective potential.

According to both companies, integrating Itamar’s home sleep testing device, WatchPAT™, with Somnoware’s proprietary cloud-based platform will accelerate the adoption of an Integrated Care Delivery Platform—an industry concept that uses workflow automation software and a care coordination platform to break down today’s device- and provider-centric silos of data-gathering and communication.

“We have formed this partnership because the current healthcare system, particularly the sleep industry, is at an inflection point,” said Subath Kamalasan, CEO of Somnoware. “Lack of care coordination and interoperability have been major contributors to the uncontrolled costs of care delivery. Itamar’s WatchPAT™ is among the most advanced devices for home sleep testing. Through this alliance, we are combining best-of-breed software and hardware, enabling customers to realize tremendous economic and business benefits.”

Marvin Slosman, president of Itamar Medical, reinforced Kamalasan’s concerns about healthcare cost control and improved care, explaining that the economic cost of unmanaged sleep apnea for the US healthcare System is enormous.

“Only about 20% of sleep apnea patients have been diagnosed,” added Slosman. “Our priority is to provide access to easy-to-use testing devices that can assist undiagnosed patients. By enabling interoperability between WatchPAT™ and Somnoware, we are creating solutions that will enable our customers to reduce cost and transition to an outcomes-based model of care.”

About Itamar Medical

Itamar Medical Ltd. is a publicly-traded medical technology company utilizing PAT™ (Peripheral Arterial Tone) signal technology and applications. The PAT signal is a non-invasive “window” to both the cardiovascular and autonomic nervous systems. WatchPAT™ is the most convenient, portable sleep testing device on the market easily installed by the patient in the comfort of their own home with over 500K tests worldwide.

To learn how Somnoware helps facilities automate their testing processes, obtain predictive insights, and drive greater patient engagement, please select this link.